Digital Lifestyle Serve - Money Making Blog
New research shows that tirzepatide, the latest FDA-approved obesity drug, really can help people lose substantial amounts of weight—but only if they continue taking it. The study found that people…
A study out this week suggests that semaglutide—the active ingredient in popular obesity drug Wegovy—might be able to help people struggling with alcohol use disorder, too. In a small sample…
There’s officially a new and fierce competitor for Novo Nordisk’s Wegovy (semaglutide) when it comes to weight loss. On Wednesday, the Food and Drug Administration approved the drug tirzepatide, developed…
Health officials in Austria are the latest to warn the public to stay away from sketchy sources of semaglutide, the active ingredient in popular weight loss drugs Wegovy and Ozempic,…
MIT scientists might be one step closer to making insulin injections a thing of the past. In a new study this week, they’ve shown that it’s possible to implant a…
A lab-made antibody could one day make organ transplants less of an ordeal, recent research suggests. In experiments with nonhuman primates, the antibody appeared to be safe and effective at…
Wegovy, the popular obesity treatment, also seems to offer heart health benefits. On Tuesday, Novo Nordisk reported the results of a comprehensive clinical trial evaluating the drug’s efficacy in preventing…
The makers of two popular but off-label weight loss drugs are now being sued over complications allegedly linked to their use. This week, a Louisiana woman filed a complaint against…
Diabetes cases are likely to skyrocket over the next few decades, new research out this week has found. The study estimates that more than a billion people worldwide will be…
New research has found a possible link between having high levels of caffeine in your blood and a reduced risk of high body fat and type 2 diabetes. The authors…